• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏手术后患者及应用阿米替林后的健康个体的血清抗胆碱能活性。

Serum anticholinergic activity in patients following cardiac surgery and healthy individuals following amitriptyline application.

作者信息

Brecht S, Reiff J, Vock U, Voget J, Ley L, Boning A, Cremer J, Aldenhoff J, Herdegen T

机构信息

Institute of Pharmacology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany.

出版信息

Methods Find Exp Clin Pharmacol. 2007 Apr;29(3):223-30. doi: 10.1358/mf.2007.29.3.1075357.

DOI:10.1358/mf.2007.29.3.1075357
PMID:17520106
Abstract

The serum anticholinergic activity (SAA) is used as a marker for cognitive impairment. Here, two studies have been performed characterizing the SAA profile. In Study 1 the endogenous SAA in relation to the total serum protein concentration was monitored for 24 h in five healthy individuals and compared with that in four inpatients following cardiac surgery. In Study 2 the SAA of seven healthy individuals was assessed following a single amitriptyline dose. In both studies SAA was assessed by an ex vivo assay. In Study 1, the absolute SAA varied in a wide range of 1.2 and 14.5 atropine equivalents (AEs) over 24 h. A circadian pattern was not observed. The mean total serum protein concentration, but not the SAA, was significantly lower in inpatients than in healthy individuals. In Study 2, the SAA increased following amitriptyline to a maximum. The mean SAA increased by 6.39 AE at the amitriptyline peak concentration. High SAA variability showed a low statistical relation to amitriptyline concentrations. Both studies characterize the SAA as an individual parameter not affected per se by surgery or clinical care and poorly correlated with the total serum protein concentration. The relation with amitriptyline concentration helps to quantify SAA values towards a better understanding of the clinical implications and limitations of SAA changes.

摘要

血清抗胆碱能活性(SAA)被用作认知障碍的标志物。在此,已开展两项研究来描述SAA特征。在研究1中,对5名健康个体的内源性SAA与总血清蛋白浓度的关系进行了24小时监测,并与4名心脏手术后的住院患者进行了比较。在研究2中,对7名健康个体单次服用阿米替林后的SAA进行了评估。在两项研究中,SAA均通过体外试验进行评估。在研究1中,24小时内绝对SAA在1.2至14.5阿托品当量(AEs)的广泛范围内变化。未观察到昼夜节律模式。住院患者的平均总血清蛋白浓度显著低于健康个体,但SAA并非如此。在研究2中,服用阿米替林后SAA升高至最大值。在阿米替林峰值浓度时,平均SAA增加了6.39 AE。SAA的高变异性与阿米替林浓度的统计关系较低。两项研究均将SAA描述为一个个体参数,本身不受手术或临床护理的影响,且与总血清蛋白浓度相关性较差。与阿米替林浓度的关系有助于量化SAA值,以便更好地理解SAA变化的临床意义和局限性。

相似文献

1
Serum anticholinergic activity in patients following cardiac surgery and healthy individuals following amitriptyline application.心脏手术后患者及应用阿米替林后的健康个体的血清抗胆碱能活性。
Methods Find Exp Clin Pharmacol. 2007 Apr;29(3):223-30. doi: 10.1358/mf.2007.29.3.1075357.
2
Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.手术前患者血浆与脑脊液抗胆碱能活性之间存在显著相关性。
Neurosci Lett. 2007 Apr 24;417(1):16-20. doi: 10.1016/j.neulet.2007.02.015. Epub 2007 Feb 9.
3
A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice.
Psychopharmacol Bull. 2002 Spring;36(2):24-39.
4
The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.作为药物相关抗胆碱能负担衡量指标的抗胆碱能药物量表:与血清抗胆碱能活性的关联。
J Clin Pharmacol. 2006 Dec;46(12):1481-6. doi: 10.1177/0091270006292126.
5
EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit.在重症监护病房中对谵妄患者进行脑电图变化及血清抗胆碱能活性测定。
Anaesthesia. 2007 Dec;62(12):1217-23. doi: 10.1111/j.1365-2044.2007.05255.x.
6
Serum anticholinergic activity and behavior following atropine sulfate administration in the rat.
Pharmacol Biochem Behav. 1997 Jan;56(1):151-4. doi: 10.1016/S0091-3057(96)00172-4.
7
Longitudinal assessment of serum anticholinergic activity in delirium of the elderly.老年谵妄患者血清抗胆碱能活性的纵向评估。
J Psychiatr Res. 2012 Oct;46(10):1339-45. doi: 10.1016/j.jpsychires.2012.06.015. Epub 2012 Jul 28.
8
Flaws in the serum anticholinergic activity assay: implications for the study of delirium.
J Am Geriatr Soc. 2009 Sep;57(9):1707-8. doi: 10.1111/j.1532-5415.2009.02411.x.
9
[Serum anticholinergic activity: relationship with clinical symptoms in Alzheimer's disease and proposal of new biological marker].[血清抗胆碱能活性:与阿尔茨海默病临床症状的关系及新生物标志物的提出]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):135-40.
10
Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.渗透泵控释片和速释阿米替林的药代动力学和药效学特征
Br J Clin Pharmacol. 1999 Jul;48(1):71-8. doi: 10.1046/j.1365-2125.1999.00973.x.

引用本文的文献

1
Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.抗胆碱能负担的检查与评估:当前趋势及对未来研究的启示
Drugs Aging. 2016 May;33(5):305-13. doi: 10.1007/s40266-016-0362-5.
2
Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature.老年人血清抗胆碱能活性与认知及功能不良结局:文献系统评价与荟萃分析
PLoS One. 2016 Mar 21;11(3):e0151084. doi: 10.1371/journal.pone.0151084. eCollection 2016.